Background/objectives A better understanding of adipose tissue biology is crucial to tackle insulin resistance and eventually coronary heart disease and diabetes, leading causes of morbidity and mortality worldwide. GALNT2, a GalNAc-transferase, positively modulates insulin signaling in human liver cells by down-regulating ENPP1, an insulin signaling inhibitor. GALNT2 expression is increased in adipose tissue of obese as compared to that of non-obese individuals. Whether this association is secondary to a GALNT2-insulin sensitizing effect exerted also in adipocytes is unknown. We then investigated in mouse 3T3-L1 adipocytes the GALNT2 effect on adipogenesis, insulin signaling and expression levels of both Enpp1 and 72 adipogenesis-related genes. Methods Stable over-expressing GALNT2 and GFP preadipocytes (T 0 ) were generated. Adipogenesis was induced with (R +) or without (R−) rosiglitazone and investigated after 15 days (T 15 ). Lipid accumulation (by Oil Red-O staining) and intracellular triglycerides (by fluorimetric assay) were measured. Lipid droplets (LD) measures were analyzed at confocal microscope. Gene expression was assessed by RT-PCR and insulin-induced insulin receptor (IR), IRS1, JNK and AKT phosphorylation by Western blot. Results Lipid accumulation, triglycerides and LD measures progressively increased from T 0 to T 15 R-and furthermore to T 15 R+. Such increases were significantly higher in GALNT2 than in GFP cells so that, as compared to T 15 R+GFP, T 15 R-GALNT2 cells showed similar (intracellular lipid and triglycerides accumulation) or even higher (LD measures, p < 0.01) values. In GALNT2 preadipocytes, insulin-induced IR, IRS1 and AKT activation was higher than that in GFP cells. GALNT2 effect was totally abolished during adipocyte maturation and completely reversed at late stage maturation. Such GALNT2 effect trajectory was paralleled by coordinated changes in the expression of Enpp1 and adipocyte-maturation key genes. Conclusions GALNT2 is a novel modulator of adipogenesis and related cellular phenotypes, thus becoming a potential target for tackling the obesity epidemics and its devastating sequelae.
Introduction
Obesity and adipose tissue dysfunction are major movers of insulin resistance, thus predisposing to leading causes of morbidity and mortality [1] , such as coronary heart disease and type 2 diabetes [2] . A better understanding of the mechanisms controlling adipogenesis is therefore of crucial importance.
Insulin stimulates lipid storage in adipocytes [3] . So, it is not surprising that insulin sensitivity prospectively predicts weight gain increase [4] . Further confirming that insulin sensitivity positively controls body weight is the common observation that thiazolidinediones-insulin sensitizing molecules used as anti-hyperglycemic drugs in type 2 diabetes-increase body mass index (BMI) [5] .
GALNT2, a GalNAc-transferase [6] involved in O-linked glycosylation [7] , modulates the risk of atherogenic dyslipidemia [8] [9] [10] [11] , a specific hallmark of insulin resistance and acts as a positive modulator of insulin signaling in human liver cells, by down-regulating ENPP1, an inhibitor of insulin receptor (IR) [12] . Interestingly, GALNT2 expression in subcutaneous adipose tissue is increased in obese, insulin resistant individuals as compared to their non-obese counterparts [13] . Whether this association underlies a cause-effect relationship, with GALNT2 firstly predisposing to weight gain by exerting a positive modulation on adipose tissue insulin signaling and eventually concurring to develop obesity and the inevitably related insulin resistance, is a reasonable possibility that has never been addressed. In order to get deeper insights about this hypothesis, we investigated in cultured mouse adipocytes the effect of GALNT2 on adipogenesis, lipid accumulation and insulin signaling.
Materials and methods

Cell culture
Both mycoplasma-free 3T3-L1 murine fibroblast (AddexBio), and 293T cells (ATCC) were routinely cultured in high-glucose Dulbecco's modified Eagle's medium (DMEM) (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS) (EuroClone) and maintained at 37°C in a humidified atmosphere with 5% CO 2 .
Recombinant Lentivirus production and transduction
Human ORF GALNT2 cloned into pLX304 vector under CMV promoter (pLXGALNT2) and both dR8.91 (Packaging plasmid) and VSV-G (Envelope plasmid), used for lentiviral production, were purchased from Harvard Medical School Facilities. Plasmid pRRL-PGK-GFP was kindly provided by F. Carlotti (Nice, FR) [14] . Lentiviral particles were generated by co-transfecting either pLXGALNT2 or pRRL-PGK-GFP with both dR8.91 and VSV-G plasmids in 293T cells by calcium phosphate method [15] . Cells were then maintained in DMEM supplemented with 30% FBS for 18 h and lentiviral particles harvested, filtered through 0.45 µm filter and stored at −80°C until used.
In order to obtain 3T3-L1 cell lines over-expressing either GFP (GFP cells) or GALNT2 (GALNT2 cells), both viral supernatants were added to fresh medium supplemented with 8 µg/ml Polybrene (Sigma-Aldrich) and 3T3-L1 cells incubated overnight. After 24 h, the medium was replaced with fresh DMEM plus 10% FBS and, then, changed every 2 days. GALNT2 transduced cells were further selected by adding 5 µg/ml of blasticidin (Thermo Fisher Scientific). GFP cells were used as control in all experiments.
3T3-L1 adipocytes differentiation
Cells were seeded either in 6-well-plates (Sigma-Aldrich) or in 18 × 18 mm sterile imaging glasses, at~8 × 10 3 cell/cm 2 cell density and grown in DMEM plus 10% FBS for 4 days in order to obtain 100% confluence (T 0 GFP and T 0 GALNT2 cells). Cell differentiation was induced, by using DMEM plus 1 µM dexamethasone (Calbiochem), 0.5 mM 1-methyl-3-isobutylxanthine (Calbiochem), 5 µg/ml human recombinant insulin (Gibco) and either with (R+) or without (R−) 2 µM rosiglitazone (Cayman Chemical). After 48 h, R+ and R− differentiation mediums were replaced with 10% FBS supplemented DMEM plus either 5 µg/ml insulin, with a biweekly medium replacement until day 15 (T 15 GFP and T 15 GALNT2 cells).
Oil Red O staining and lipid quantification
Oil Red-O (ORO) staining was performed in T 0 , T 15 R− and T 15 R+cells as it follows. Briefly, cells were fixed with 10% formalin for at least 1 h, rinsed with 60% isopropyl alcohol and, after complete drying, treated with ORO for 10 min. Cells were then washed 4 times with deionized H 2 O and dried. Embedded ORO, an inferred measures of intracellular lipids, was eluted, by adding 100% isopropyl alcohol for 10 min, and quantified at 500 nm by Synergy-HT spectrophotometer (Bio-Tek). The resulting optical densities (OD) were expressed as percentage on either T 0 GFP or T 0 GALNT2 cells, respectively. Intracellular triglycerides levels were measured in T 0 , T 15 R− and T 15 R+cells by means of the fluorimetric enzymatic Adipogenesis Assay Kit according to manufacturer's instruction (Sigma-Aldrich). The resulting fluorimetric intensities were measured at 587 nm by Synergy-HT Fluorimeter (Bio-Tek), plotted versus a triglycerides standard curve and expressed as nmol/5000 cells.
Adipo Red staining
T 0 , T 15 R− and T 15 R+cells were rinsed twice with phosphate-buffer saline (PBS), fixed with 4% paraformaldehyde for 15 min and then incubated with Adipo Red stain (Lonza) for 10 min. Next, cells were washed with PBS and adipocyte lipid droplets (LD) imaged.
Imaging
ORO-stained cells were imaged in bright field by means of an inverted microscope (Axiovert 2 M, Zeiss) at ×5 magnification (Zeiss FLUAR 5 × /0.25na objective).
Images' acquisition of Adipo Red-stained adipocytes was performed by using a TCS SP8 confocal microscope (Leica) at ×40 magnification (HC PL APO CS2 40 × /1.30 OIL Leica objective). At least 30 independent micrographs were acquired for each experimental condition. LD morphology was then analyzed by using Cell Profiler software. Briefly, images were segmented to identify lipids as discrete "objects" and then area and Feret's diameter (which account for LD size, in terms of diameter for rounded objects or major axis for irregular objects) were measured. 
Western blot analysis
Insulin signaling
Cells were starved for 18 h with DMEM plus 0.5% FBS, stimulated with 10 −7 M insulin for 5 min at 37°C, and then washed with PBS and lysed. To evaluate IR β-subunit autophosphorylation, 300 µg of total lysate were immuneprecipitated with anti-PY99 antibody (sc-7020, Santa Cruz Biotechnology) and analyzed by Western blot as described above. To evaluate IRS1, JNK and AKT activation, 50 µg of total lysate were subjected to SDS-Page and IRS1 Tyr895 , JNK1/JNK2 Thr183/Tyr185 and AKT Ser473 phosphorylation evaluated by western blot (see above). IRS1
Tyr895 , JNK1/ JNK2 Thr183/Tyr185 and AKT Ser473 phosphorylation levels were normalized against IRS1, JNK and AKT content. All data were calculated as percentage of insulin-stimulated GFP adipocytes and expressed as means ± SE.
RNA extraction, cDNA synthesis, and gene expression analysis Total RNA was isolated from mature adipocytes by using RNeasy Mini kit (Qiagen). cDNA was generated by reverse transcription with iScript™ Reverse Transcription Supermix for RT-qPCR (Biorad) according to the manufacturer's instructions and used as template for subsequent analyses. Expression levels of 72 adipogenesis-related genes (Gene Target List can be found in Supplementary Information 1) were assessed by means of pre-designed Adipogenesis M384 SYBR green panels (Biorad), on ABI-PRISM 7900 (Applied Biosystems). Among 8 reference genes (see Supplementary Information 1) , β-actin, Gusb and Hsp90ab1 were chosen as those showing the best control gene-stability measured as indicated by M value (i.e., M < 0.5) across samples [16] . PrimeTime qPCR Probe Assays (Integrated DNA Technologies) were used to measure expression levels of Ennp1 (Mm.PT.58.7142160), mGalnt2 (Mm.PT.58.5475747) and hGALNT2 (Hs.PT.58.3633908) on ABI-PRISM 7900 (Applied Biosystems). Gene expression levels were reported as ΔΔCq, calculated as relative gene quantity normalized to the geometric mean of reference genes (PrimePCR™ Analysis Software, Biorad).
Statistical analyses
Each experiment, for each condition, has been carried out at least 3 times in duplicate. Differences between mean values were evaluated by Student's t-test; a two sided p-values < 0.05 were considered for statistical significance. Data are presented as means ± SE. Analyses were performed by using SAS Software, Release 9.4 (SAS Institute, Cary, NC, USA).
Results
Over-expression of GALNT2 in 3T3-L1 cells
Firstly, 3T3-L1 cell lines expressing either GFP (GFP cells) or GALNT2 (GALNT2 cells) were created as described in methods. As compared to GFP cells, a clear band representing human GALNT2 was detectable at~60 KDa in GALNT2 cells at both T 0 (preadipocytes, Fig. 1a ) and T 15 (mature adipocytes, Fig. 1b) .
Role of GALNT2 on mature adipocyte proportion and lipid accumulation
Adipogenesis was then induced for 15 days in T 0 GFP and T 0 GALNT2 cells. Figure 2a shows representative micrographs of undifferentiated T 0 cells (images 1 and 4) and mature adipocytes, either T 15 R− (images 2 and 5) or T 15 R +(images 3 and 6). In GFP cells, the apparent proportion of mature adipocytes progressively increased from T 0 to T 15 Rand to T 15 R+ (images 1-3). A similar, though stronger, increase was observed in GALNT2 cells (images 4-6). In fact, as compared to GFP cells, the proportion of mature adipocytes appeared to be higher in their GALNT2 counterparts (image 5 vs. 2 and image 6 vs. 3). In addition, the proportion of mature adipocytes in T 15 R−GALNT2 cells looked quite similar to that in T 15 R+GFP cells (image 5 vs. 3), as if the magnitude of GALNT2 effect were similar to that of rosiglitazone. Figure 2b (left side) shows that, as compared to T 0 GFP cells, lipid content was significantly increased in T 15 R− (1.7 fold-increase) and even more in T 15 R+ (2.2 fold-increase) GFP cells. A similar, though stronger, trend was observed also in GALNT2 cells (Fig. 2b , right side), with differences vs. their T 15 GFP counterparts becoming significant (p = 0.01) for the T 15 R+condition (Fig. 2b, black bars) . It is worth noticing that lipid accumulation in T 15 R−GALNT2 cells was virtually identical to that in T 15 R+GFP cells (Fig.  2b , right side white bar vs. left side black bar).
Very similar results were obtained when intracellular triglycerides levels were measured. In fact, as compared to T 0 GFP cells (Fig. 2c, left side) , triglycerides were significantly increased in T 15 R− (3.5-fold-increase) and even more in T 15 R+ (4.2-fold-increase) GFP cells. An even stronger trend was observed in GALNT2 cells (Fig. 2c , right side), with differences vs. their T 15 GFP counterparts being significant for both T 15 R− (p = 0.019) and T 15 R+ (p = 0.034) conditions (Fig. 2c , white bars and black bars, respectively). Also in this case, it is worth noticing that triglycerides accumulation in T 15 R−GALNT2 cells was virtually identical to that in T 15 R+GFP cells (Fig. 2c , right side white bar vs. left side black bar). Then, for both lipid accumulation and triglycerides content, these results parallel those referring to the proportion of mature adipocytes and give further support to the concept that the magnitude of GALNT2 stimulatory effect on adipogenesis is similar to that of rosiglitazone. Fig. 1 Over-expression of GALNT2 in 3T3-L1 cells. 3T3-L1 cells were transduced with either pLX304_GALNT2 or pLV-CMV-GFP as described in Materials and Methods. GALNT2 expression was evaluated at T 0 (a) and T 15 (b) by western blot. In brief, equal amounts of protein from cell lysates were separated by SDS-PAGE and probed with GALNT2 (upper blot) or β-actin (lower blot) specific antibodies
Role of GALNT2 on droplet morphology in mature adipocytes
Representative LD images in mature adipocytes are shown in Fig. 3a . In both cell lines, rosiglitazone treatment increased LD size and roundness (Fig. 3a, panel 2 (Fig. 3a, panel 3 vs. 2), again pointing to an effect of GALNT2 over-expression of a similar magnitude of rosiglitazone.
LD morphology was measured by means of 2 shape descriptors (Figs. 3b, c) , including area and size. As compared to their T 15 R-counterparts, LD area was significantly increased in both T 15 R+GFP and GALNT2 cells (Fig. 3b) , while LD size was significantly higher only in T 15 R+GFP cells, with only mild, non-significant increase showed by GALNT2 cells (Fig. 3c) . LD area and size in GALNT2 cells were significantly increased as compared to their GFP counterparts, both without and with rosiglitazone treatment (Figs. 3b, c) . Notably, LD area and size in T 15 R-GALNT2 cells were significantly greater than those of T 15 R+GFP cells (Figs. 3b, c) , thus indicating that the effect of GALNT2 over-expression in modulating also this additional adipogenesis-related phenotype is at least similar if not larger than that of rosiglitazone.
Taken altogether, our data indicate that GALNT2 has a positive role on 3T3-L1 differentiation, lipid accumulation and LD morphology whose magnitude resembles very much that of rosiglitazone.
Role of GALNT2 on insulin signaling
Given that adipocyte maturation is under the control of insulin signaling, time course experiments of insulininduced IR, IRS1, AKT and JNK1/JNK2 phosphorylation were carried out, so to get deeper insights on the molecular mechanisms underlying GALNT2 effect on adipocyte enlargement. In both GFP and GALNT2 cells, a clear insulin stimulation of IR β-subunit auto-phosphorylation, IRS1
Tyr895 and AKT Ser473 phosphorylation (Figs. 4a-c, respectively) was observed at T 0 , T 9 and T 15 . In GALNT2 preadipocytes, insulin-induced IR was significantly higher than that observed in GFP cells (Fig. 4a, T 0 ) . This GALNT2 stimulatory effect was no longer observed during adipocyte maturation (Fig. 4a, T 9 ), and totally reversed at late stage maturation, where GALNT2 enlarged adipocytes showed a significantly reduced insulin-induced IR phosphorylation (Fig. 4a, T 15 ) . A virtually identical trend of GALNT2 effect was observed for both insulin-induced IRS1 and AKT activation (Figs. 4b, c) , though statistical significance for IRS1 stimulation in preadipocytes (T 0 ) was not reached.
Finally, as compared to their GFP counterparts, insulininduced JNK1/JNK2 Thr183/Tyr185 was similar in GALNT2 In all, data in preadipocytes are definitively consistent with the reported positive role of GALNT2 on insulin sensitivity in other cell types [12] , which in turn stimulates adipocyte maturation and eventually adipocyte enlargement [17] . Conversely, the reduced insulin signaling in mature GALNT2 adipocytes is fully compatible with the wellknown decreased insulin sensitivity characterizing enlarged adipocytes [18, 19] .
Role of GALNT2 on the expression of ENPP1 and genes related to adipogenesis
Firstly, the expression of Enpp1, a negative modulator of insulin signaling whose expression in liver cells is decreased by GALNT2 [12] , was evaluated. In fact, as compared to GFP counterparts, in GALNT2 cells Enpp1 expression was similar at T 0 (1.15 fold, n = 3) and was progressively down-regulated at T 9 (1.6 fold-decrease, n = 3) and even more strikingly at T 15 (6.9-fold-decrease, n = 3 ). Of note, such Enpp1 down-regulation was not paralleled by changes in Galnt2 expression in T 9 and T 15 as compared to T 0 (fold-change at both time points ranging from −1.4 to 1.2, n = 3). Finally, also no changes were observed during adipogenesis in the expression of hGALNT2 in transfected cells (data not shown, n = 3).
Then, expression levels of 72 adipogenesis-related genes were measured during adipocyte maturation, at T 0 (Fig. 5a ), T 9 ( Fig. 5b) and T 15 (Fig. 5c) . At each time point, several genes were at least 2-fold changed in GALNT2 cells as compared to their GFP counterparts. In details, 6 genes were either increased (Hes1) or decreased (Agt, Foxc2, Klf15, Ucp1, Wnt5a) at T 0 , 13 were either increased (Adig, Adipoq, Retn, Bmp4, Hes1) or decreased (Agt, Cebpb, Gata2, Lipe, Rxra, Tsc22d3, Ucp1, Wnt5a) at T 9 , and 21 were either increased (Adig, Adipoq, Adrb2, Cebpa, Fabp4, Nr1h3, Retn, Wnt5b) or decreased (Agt, Egr2, Fgf2, Gata2, Insr, Lipe, Runx1t1, Rxra, Slc2a4, Tsc22d3, Ucp1, Wnt1, Wnt5a) at T 15 . Of these 21 genes, 3 were already downregulated at T 0 and maintained as such also at T 9 (Agt, Ucp1, Wnt5a), while 7 were either upregulated (Adig, Adipoq, Retn) or downregulated (Gata2, Lipe, Rxra, Tsc22d3) only starting from T 9 .
In all, these results strongly suggest that GALNT2 induces a coordinated and time-dependent change in the expression of adipocyte maturation key genes which is likely to have played a role on the different adipogenesis observed in GALNT2 as compared to GFP cells.
Discussion
Our previous work pointed GALNT2 as a positive modulator of insulin signaling in human liver cells [12, [18] [19] [20] [21] . Based on the notion that GALNT2 expression is increased in subcutaneous adipose tissue of obese individuals [13] and that insulin signaling stimulates adipocytes differentiation [3] , we have now tested the hypothesis that GALNT2 exerts a stimulatory role on adipogenesis.
As a matter of fact, our data clearly show that in 3T3-L1 mouse cells GALNT2 stimulates adipogenesis as indicated by increased proportion of mature adipocytes, intracellular lipids, including triglycerides, and lipid droplets dimension.
Of note, the magnitude of GALNT2 stimulatory effect on adipogenesis was relevant, being superimposable to that exerted by rosiglitazone [5] , a potent stimulator of adipogenesis [22] known to cause weight gain in patients with type 2 diabetes [5] .
GALNT2 stimulatory effect on adipogenesis was paralleled by improved insulin signaling in preadipocytes. This effect was abolished during adipocyte maturation and completely reversed at late stage maturation as a possible consequence of adipocytes enlargement [18] [19] [20] [21] . These data suggest that if adipocytes are pushed to maturation from the very early stages, the whole adipogenesis until late stage and ultimate adipocytes enlargement is heavily compromised.
During adipogenesis GALNT2 cells were also characterized by Enpp1 down-regulation, a negative modulator of insulin signaling [23] [24] [25] , thus confirming previous data we reported in human cultured liver cells over-expressing GALNT2 [12] . Taken together these two piece of data strongly suggest that during cell differentiation GALNT2 down-regulated Enpp1, so increasing insulin signaling and stimulating adipogenesis [12, 26] ; however, once adipogenesis was established, the positive GALNT2 effect on insulin signaling, was eventually overwhelmed by the opposite deleterious effect on the same insulin signaling ineludibly exerted by adipocytes enlarging [18] [19] [20] [21] . This latter phenomenon, which is likely part of the adipocyte homeostatic response aimed at impeding further enlargement under conditions of continuous insulin stimulation Fig. 4 Role of GALNT2 on insulin signaling. GFP and GALNT2 cells were stimulated with 10 −7 M insulin and then IR β-subunit (a), IRS1 Tyr895 (b) and AKT Ser473 (c) phosphorylation were evaluated by Western blot analyses as described in Materials and Methods. a Bars represent quantitative analysis of IR β-subunit phosphorylation expressed as percentage of that observed in insulin-stimulated GFP cells (white bars) at T 0 (n = 3), T 9 (n = 3), and T 15 (n = 6). b Bars represent quantitative analyses of insulin-induced IRS1 Tyr895 phosphorylation/IRS1 OD ratio expressed as percentage of that observed in insulin-stimulated GFP cells (white bars) at each time points (T 0 , T 9 and T 15 , n = 3 at all time points). c Bars represent quantitative analyses of insulin-induced AKT Ser473 phosphorylation/AKT OD ratio, expressed as percentage of that observed in insulin-stimulated GFP cells (white bars) at T 0 (n = 3), T 9 (n = 3) and T 15 (n = 6). All data are means ± SE. *2 sided p < 0.05 by Student's t-test. A representative blot for each experimental condition is shown [27] [28] [29] , is paralleled and may be, therefore, at least partly explained by the strikingly increased levels of resistin gene (Retn) [30] observed during adipogenesis in GALNT2 overexpressing cells.
The insulin resistant phenotype we observed in GALNT2 mature adipocytes might be also explained by ceramidesdependent mechanisms, known to inhibit insulin signaling, through the PKR/JNK pathway [31] . However, although we do acknowledge that lack of ceramides data is a limitation of our study, data showing no changes between GFP and GALNT2 cells in insulin-induced JNK phosphorylation, make unlikely that ceramides-dependent mechanisms are involved in reducing insulin signaling in GALNT2 mature adipocytes.
In addition, it cannot be excluded that GALNT2 affects adipogenesis also independently of insulin signaling. For example, the coordinated change in the expression of key maturation genes we observed along the whole course of adipogenesis may have also played a role in mediating GALNT2 promoted adipocyte enlargement. In fact, the expression of some genes that are either up-regulated (Adig, Retn, Nr1h3) or down-regulated (Ucp1, Slc2a4, Lipe, Fgf2, Tcs22d3) in GALNT2 cells, has been previously reported to associate with adipocytes lipid storage [32] and adiposity measures [33] [34] [35] [36] [37] [38] [39] , toward a coherent direction with our present findings.
GALNT2 is involved in O-glycosylation (i.e., the sequential addition of different monosaccharides to proteins) an intracellular processing step of utmost importance [40] . This also may have played a role in mediating GALNT2 effect on adipogenesis. At this regard, increased GALNT2 downstream glycosylation processes up-regulate CEBPa and AdipoQ [41] , whose expression was in fact increased during adipocytes maturation in GALNT2 cells.
Finally, no matter the mechanisms mediating its effects on adipogenesis, our finding envisions GALNT2 as an attractive drug-target for tackling increased expansion of adipose tissue and, therefore, the worldwide epidemic of obesity and related dramatic sequelae. In fact, both gene silencing and binding prevention tools are novel strategies hoped to pave the way for inventing new treatments in the field of metabolic diseases [42, 43] . Conversely, since thiazolinediones have been proposed for treating lipodystrophies of any origin [5, 44, 45] , and since our data show that the magnitude of GALNT2 stimulatory effect on adipogenesis is similar to that of rosiglitazone, one could also speculate that GALNT2 up-regulation might be a rational approach for treating these conditions.
In conclusion, our data indicate that GALNT2 is a positive modulator of adipocytes insulin signaling and point it as a novel promoter of adipogenesis which eventually causes adipocytes enlargement. Further studies are needed to get deeper insights on the precise mechanisms by which GALNT2 exerts its effects on adipocyte biology and to address whether it may become a new target for treating states of abnormal expansion of adipose tissue. 
